Bing Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Bing Li has a total of 93 co-authors. Here are the top co-authors by number of shared publications:
Yang Yang
Department of Orthopaedics, Tianjin Hospital, Tianjin, China
4 shared publicationsYang Zhang
Tianjin Orthopedic Research Institute Tianjin China
4 shared publicationsHaobo Jia
Department of Orthopaedics, Tianjin Hospital, Tianjin, China
3 shared publicationsJianxiong Ma
Tianjin Orthopedic Research Institute Tianjin China
3 shared publicationsJie Zhao
Orthopedic Department, Tianjin Hospital, Tianjin 300211, People's Republic of China
3 shared publicationsJun Liu
Department of Joint Surgery, Tianjin Hospital, Tianjin Medical University, Tianjin 300211, P.R. China
3 shared publications
Latest Publications
- Open Access
- 6 November 2023
- Published by SAGE Publications in Orthopaedic Journal of Sports Medicine
- Vol. 11 (11)
Influence of Inflammatory Bowel Disease on Patients Undergoing Primary Total Joint Arthroplasty: A Systematic Review and Meta-analysis of Cohort Studies
Background: Inflammatory bowel disease (IBD) is recognized as a global disease. Although IBD is commonly diagnosed in the young male population, it also occurs in patients aged >60 years. With the advent of an aging society, it is expected that an increasing number of patients with IBD will undergo total joint arthroplasty (TJA). Purpose: To assess the impact of IBD on the risk of complications and revision as well as the length of stay (LOS) and treatment costs after TJA. Study Design: Systematic review; Level of evidence, 4. Methods: Utilizing PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, articles were searched in the PubMed/MEDLINE, Embase, and Cochrane Library databases from the date of inception to August 31, 2022, using the following search terms: (1) “Inflammatory Bowel Diseases”[MeSH] and (2) “Arthroplasty, Replacement”[MeSH]. The study quality was scored according to the Newcastle-Ottawa Scale. A fixed-effects or random-effects model was used to calculate odds ratios or mean differences with 95% confidence intervals. Results: Of 232 studies initially retrieved, 8 retrospective cohort studies consisting of 33,758 patients with IBD and 386,238 patients without IBD were included. Patients with IBD had a higher incidence of complications ( P < .05), readmission and revision ( P < .05), experienced a longer LOS ( P < .01), and paid higher treatment costs after TJA compared with patients without IBD . Conclusion: The results of our review demonstrated that IBD increased the risk of postoperative complications, prolonged the LOS, and increased treatment costs.
- 6 November 2023
- Published by SAGE Publications in Orthopaedic Journal of Sports Medicine
- Vol. 11 (11)
Open AccessInfluence of Inflammatory Bowel Disease on Patients Undergoing Primary Total Joint Arthroplasty: A Systematic Review and Meta-analysis of Cohort Studies
Background: Inflammatory bowel disease (IBD) is recognized as a global disease. Although IBD is commonly diagnosed in the young male population, it also occurs in patients aged >60 years. With the advent of an aging society, it is expected that an increasing number of patients with IBD will undergo total joint arthroplasty (TJA). Purpose: To assess the impact of IBD on the risk of complications and revision as well as the length of stay (LOS) and treatment costs after TJA. Study Design: Systematic review; Level of evidence, 4. Methods: Utilizing PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, articles were searched in the PubMed/MEDLINE, Embase, and Cochrane Library databases from the date of inception to August 31, 2022, using the following search terms: (1) “Inflammatory Bowel Diseases”[MeSH] and (2) “Arthroplasty, Replacement”[MeSH]. The study quality was scored according to the Newcastle-Ottawa Scale. A fixed-effects or random-effects model was used to calculate odds ratios or mean differences with 95% confidence intervals. Results: Of 232 studies initially retrieved, 8 retrospective cohort studies consisting of 33,758 patients with IBD and 386,238 patients without IBD were included. Patients with IBD had a higher incidence of complications ( P < .05), readmission and revision ( P < .05), experienced a longer LOS ( P < .01), and paid higher treatment costs after TJA compared with patients without IBD . Conclusion: The results of our review demonstrated that IBD increased the risk of postoperative complications, prolonged the LOS, and increased treatment costs.
- 29 January 2022
- Published by Elsevier in Materials Today Communications
- Vol. 30, 103206
Enhanced osseointegration of 3D-printed cementless tibial prostheses with trabecular metal surfaces in a novel three-partition design
- 29 January 2022
- Published by Elsevier in Materials Today Communications
- Vol. 30, 103206
Enhanced osseointegration of 3D-printed cementless tibial prostheses with trabecular metal surfaces in a novel three-partition design
- Open Access
- 1 August 2021
- Published by IOP Publishing in Journal of Physics: Conference Series
- Vol. 1992 (4) , 042040
The Efficacy and Safety of Wuling Powder on Cirrhotic Ascites: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Objective To evaluate the efficacy and safety in patients with cirrhotic ascites treated by Wuling Powder. Methods PubMed, Web of science, The Cochrane library, EMbase, CNKI, WAFANG, VIP and SinoMed database were searched. Randomized controlled studies of cirrhotic ascites were collected from the establishment of the database to February 20, 2020. EndNote was used for literature screening, RevMan 5.3 was used for data analysis, GRADEpro was used to evaluate the evidence quality. Results 11 studies with 1054 patients were analyzed, Meta-analysis: @@@2460;Total effective rate: The Wuling powder group was higher (P Conclusions The Wuling powder combined with basic western medical treatment for cirrhotic ascites can significantly improve clinical efficiency, liver function and reduce recurrence rate, the adverse events were not obvious. However, due to the low quality of the included studies, it should be used with caution in the clinic.
- 1 August 2021
- Published by IOP Publishing in Journal of Physics: Conference Series
- Vol. 1992 (4) , 042040
Open AccessThe Efficacy and Safety of Wuling Powder on Cirrhotic Ascites: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Objective To evaluate the efficacy and safety in patients with cirrhotic ascites treated by Wuling Powder. Methods PubMed, Web of science, The Cochrane library, EMbase, CNKI, WAFANG, VIP and SinoMed database were searched. Randomized controlled studies of cirrhotic ascites were collected from the establishment of the database to February 20, 2020. EndNote was used for literature screening, RevMan 5.3 was used for data analysis, GRADEpro was used to evaluate the evidence quality. Results 11 studies with 1054 patients were analyzed, Meta-analysis: @@@2460;Total effective rate: The Wuling powder group was higher (P Conclusions The Wuling powder combined with basic western medical treatment for cirrhotic ascites can significantly improve clinical efficiency, liver function and reduce recurrence rate, the adverse events were not obvious. However, due to the low quality of the included studies, it should be used with caution in the clinic.
- Open Access
- 1 December 2020
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 36 (5) , 956-967
Cross-talk Between Histone and DNA Methylation Mediates Bone Loss in Hind Limb Unloading
Bone loss induced by mechanical unloading is a common skeletal disease, but the precise mechanism remains unclear. The current study investigated the role of histone methylation, a key epigenetic marker, and its crosstalk with DNA methylation in bone loss induced by mechanical unloading. The expression of G9a, ubiquitin‐like with PHD and ring finger domains 1 (UHRF1), and DNA methylation transferase 1 (DNMT1) were increased in hind limb unloading (HLU) rats. This was accompanied by an increased level of histone H3 lysine 9 (H3K9) di‐/tri‐methylation at lncH19 promoter. Then, alteration of G9a, DNMT1 or UHRF1 expression significantly affected lncH19 levels and osteogenic activity in UMR106 cells. Osteogenic gene expression and matrix mineralization were robustly promoted after simultaneous knockdown of G9a, DNMT1 and UHRF1. Furthermore, physical interactions of lncH19 promoter with G9a and DNMT1, as well as direct interactions among DNMT1, G9a, and UHRF1 were detected. Importantly, overexpression of DNMT1, G9a or UHRF1, respectively, resulted in enrichment of H3K9me2/me3 and 5‐methylcytosine at lncH19 promoter. Finally, in vivo rescue experiments indicated that knockdown of DNMT1, G9a or UHRF1 significantly relieved bone loss in HLU rats. In conclusion, our research demonstrated the critical role of H3K9 methylation and its crosstalk with DNA methylation in regulating lncH19 expression and bone loss in HLU rats. Combined targeting of DNMT1, G9a and UHRF1 could be a promising strategy for the treatment of bone loss induced by mechanical unloading.
- 1 December 2020
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 36 (5) , 956-967
Open AccessCross-talk Between Histone and DNA Methylation Mediates Bone Loss in Hind Limb Unloading
Bone loss induced by mechanical unloading is a common skeletal disease, but the precise mechanism remains unclear. The current study investigated the role of histone methylation, a key epigenetic marker, and its crosstalk with DNA methylation in bone loss induced by mechanical unloading. The expression of G9a, ubiquitin‐like with PHD and ring finger domains 1 (UHRF1), and DNA methylation transferase 1 (DNMT1) were increased in hind limb unloading (HLU) rats. This was accompanied by an increased level of histone H3 lysine 9 (H3K9) di‐/tri‐methylation at lncH19 promoter. Then, alteration of G9a, DNMT1 or UHRF1 expression significantly affected lncH19 levels and osteogenic activity in UMR106 cells. Osteogenic gene expression and matrix mineralization were robustly promoted after simultaneous knockdown of G9a, DNMT1 and UHRF1. Furthermore, physical interactions of lncH19 promoter with G9a and DNMT1, as well as direct interactions among DNMT1, G9a, and UHRF1 were detected. Importantly, overexpression of DNMT1, G9a or UHRF1, respectively, resulted in enrichment of H3K9me2/me3 and 5‐methylcytosine at lncH19 promoter. Finally, in vivo rescue experiments indicated that knockdown of DNMT1, G9a or UHRF1 significantly relieved bone loss in HLU rats. In conclusion, our research demonstrated the critical role of H3K9 methylation and its crosstalk with DNA methylation in regulating lncH19 expression and bone loss in HLU rats. Combined targeting of DNMT1, G9a and UHRF1 could be a promising strategy for the treatment of bone loss induced by mechanical unloading.
- Open Access
- 10 July 2020
- Published by Springer Nature in BMC Molecular and Cell Biology
- Vol. 21 (1) , 1-11
A long non-coding RNA, HOTAIR, promotes cartilage degradation in osteoarthritis by inhibiting WIF-1 expression and activating Wnt pathway
Background: Long noncoding RNAs (lncRNAs) are recently found to be critical regulators of the epigenome. However, our knowledge of their role in osteoarthritis (OA) development is limited. This study investigates the mechanism by which HOTAIR, a key lncRNA with elevated expression in OA, affects OA disease progression. Results: HOTAIR expression was greatly elevated in osteoarthritic compared to normal chondrocytes. Silencing and over-expression of HOTAIR in SW1353 cells respectively reduced and increased the expression of genes associated with cartilage degradation in OA. Investigation of molecular pathways revealed that HOTAIR acted directly on Wnt inhibitory factor 1 (WIF-1) by increasing histone H3K27 trimethylation in the WIF-1 promoter, leading to WIF-1 repression that favours activation of the Wnt/β-catenin pathway. Conclusions: Activation of Wnt/β-catenin signalling by HOTAIR through WIF-1 repression in osteoarthritic chondrocytes increases catabolic gene expression and promotes cartilage degradation. This is the first study to demonstrate a direct link between HOTAIR, WIF-1 and OA progression, which may be useful for future investigations into disease biomarkers or therapeutic targets.
- 10 July 2020
- Published by Springer Nature in BMC Molecular and Cell Biology
- Vol. 21 (1) , 1-11
Open AccessA long non-coding RNA, HOTAIR, promotes cartilage degradation in osteoarthritis by inhibiting WIF-1 expression and activating Wnt pathway
Background: Long noncoding RNAs (lncRNAs) are recently found to be critical regulators of the epigenome. However, our knowledge of their role in osteoarthritis (OA) development is limited. This study investigates the mechanism by which HOTAIR, a key lncRNA with elevated expression in OA, affects OA disease progression. Results: HOTAIR expression was greatly elevated in osteoarthritic compared to normal chondrocytes. Silencing and over-expression of HOTAIR in SW1353 cells respectively reduced and increased the expression of genes associated with cartilage degradation in OA. Investigation of molecular pathways revealed that HOTAIR acted directly on Wnt inhibitory factor 1 (WIF-1) by increasing histone H3K27 trimethylation in the WIF-1 promoter, leading to WIF-1 repression that favours activation of the Wnt/β-catenin pathway. Conclusions: Activation of Wnt/β-catenin signalling by HOTAIR through WIF-1 repression in osteoarthritic chondrocytes increases catabolic gene expression and promotes cartilage degradation. This is the first study to demonstrate a direct link between HOTAIR, WIF-1 and OA progression, which may be useful for future investigations into disease biomarkers or therapeutic targets.
Photoactivatable RNA N6‐Methyladenosine Editing with CRISPR‐Cas13
RNA has important and diverse biological roles, but the molecular methods to manipulate it spatiotemporally are limited. Here, an engineered photoactivatable RNA N6‐methyladenosine (m6A) editing system with CRISPR‐Cas13 is designed to direct specific m6A editing. Light‐inducible heterodimerizing proteins CIBN and CRY2PHR are fused to catalytically inactive PguCas13 (dCas13) and m6A effectors, respectively. This system, referred to as PAMEC, enables the spatiotemporal control of m6A editing in response to blue light. Further optimization of this system to create a highly efficient version, known as PAMECR, allows the manipulation of multiple genes robustly and simultaneously. When coupled with an upconversion nanoparticle film, the optogenetic operation window is extended from the visible range to tissue‐penetrable near‐infrared wavelengths, which offers an appealing avenue to remotely control RNA editing. These results show that PAMEC is a promising optogenetic platform for flexible and efficient targeting of RNA, with broad applicability for epitranscriptome engineering, imaging, and future therapeutic development.
Photoactivatable RNA N6‐Methyladenosine Editing with CRISPR‐Cas13
RNA has important and diverse biological roles, but the molecular methods to manipulate it spatiotemporally are limited. Here, an engineered photoactivatable RNA N6‐methyladenosine (m6A) editing system with CRISPR‐Cas13 is designed to direct specific m6A editing. Light‐inducible heterodimerizing proteins CIBN and CRY2PHR are fused to catalytically inactive PguCas13 (dCas13) and m6A effectors, respectively. This system, referred to as PAMEC, enables the spatiotemporal control of m6A editing in response to blue light. Further optimization of this system to create a highly efficient version, known as PAMECR, allows the manipulation of multiple genes robustly and simultaneously. When coupled with an upconversion nanoparticle film, the optogenetic operation window is extended from the visible range to tissue‐penetrable near‐infrared wavelengths, which offers an appealing avenue to remotely control RNA editing. These results show that PAMEC is a promising optogenetic platform for flexible and efficient targeting of RNA, with broad applicability for epitranscriptome engineering, imaging, and future therapeutic development.
- Open Access
- 5 April 2018
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 17 (6) , 7789-7796
MicroRNA‑148a inhibition protects against ovariectomy‑induced osteoporosis through PI3K/AKT signaling by estrogen receptor α
The present study aimed to investigate the effect of microRNA‑148a downregulation on osteoporosis by using an ovariectomized rat model. Reverse transcription‑quantitative polymerase chain reaction was used to analyze microRNA‑148a expression levels, MTT and flow cytometry assays were used to examine cytotoxicity and apoptosis, respectively. The gap‑associated proteins were quantified using western blotting. The expression of microRNA‑148a was significantly increased in osteoporosis rat following ovariectomy. Overexpression of microRNA‑148a significantly promoted apoptosis and inhibited cell growth, whereas downregulation of microRNA‑148a significantly reduced apoptosis and increased cell growth. Overexpression of microRNA‑148a significantly reduced estrogen receptor a (ERα) protein expression and suppressed phosphoinositide‑3‑kinase regulatory subunit 1 (PI3K) and phosphorylated‑protein kinase B (AKT) protein expression in osteoblasts in vitro. The inhibition of ERα increased the microRNA‑148a effect on apoptosis in osteoblasts in vitro. Subsequently, LY294002, an PI3K inhibitor, significantly increased the effect of microRNA‑148a on apoptosis in osteoblasts in vitro. The findings of the present study revealed that anti‑microRNA‑148a protected cells against ovariectomy‑induced osteoporosis through ERα by PI3K/AKT signaling.
- 5 April 2018
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 17 (6) , 7789-7796
Open AccessMicroRNA‑148a inhibition protects against ovariectomy‑induced osteoporosis through PI3K/AKT signaling by estrogen receptor α
The present study aimed to investigate the effect of microRNA‑148a downregulation on osteoporosis by using an ovariectomized rat model. Reverse transcription‑quantitative polymerase chain reaction was used to analyze microRNA‑148a expression levels, MTT and flow cytometry assays were used to examine cytotoxicity and apoptosis, respectively. The gap‑associated proteins were quantified using western blotting. The expression of microRNA‑148a was significantly increased in osteoporosis rat following ovariectomy. Overexpression of microRNA‑148a significantly promoted apoptosis and inhibited cell growth, whereas downregulation of microRNA‑148a significantly reduced apoptosis and increased cell growth. Overexpression of microRNA‑148a significantly reduced estrogen receptor a (ERα) protein expression and suppressed phosphoinositide‑3‑kinase regulatory subunit 1 (PI3K) and phosphorylated‑protein kinase B (AKT) protein expression in osteoblasts in vitro. The inhibition of ERα increased the microRNA‑148a effect on apoptosis in osteoblasts in vitro. Subsequently, LY294002, an PI3K inhibitor, significantly increased the effect of microRNA‑148a on apoptosis in osteoblasts in vitro. The findings of the present study revealed that anti‑microRNA‑148a protected cells against ovariectomy‑induced osteoporosis through ERα by PI3K/AKT signaling.
- 1 March 2018
- Published by Elsevier in Autoimmunity Reviews
- Vol. 17 (3) , 215-225
The anti-inflammatory effects of statins on patients with rheumatoid arthritis: A systemic review and meta-analysis of 15 randomized controlled trials
- 1 March 2018
- Published by Elsevier in Autoimmunity Reviews
- Vol. 17 (3) , 215-225
The anti-inflammatory effects of statins on patients with rheumatoid arthritis: A systemic review and meta-analysis of 15 randomized controlled trials